Literature DB >> 24379141

MTHFR genetic polymorphisms may contribute to the risk of chronic myelogenous leukemia in adults: a meta-analysis of 12 genetic association studies.

Bin Li1, Jian Zhang, Lei Wang, Yan Li, Juping Jin, Limei Ai, Chong Li, Zhe Li, Shudan Mao.   

Abstract

Chronic myelogenous leukemia (CML) is a complex disease with a genetic basis. The genetic association studies (GASs) that have investigated the association between adult CML and 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms have produced contradictory and inconclusive results. The aim of this meta-analysis is to provide a relatively comprehensive assessment of the association of these polymorphisms with adult CML risk. A literature search for eligible GAS published before September 15, 2013 was conducted in PubMed, Embase, Web of Science, Cochrane Library, and China National Knowledge Infrastructure (CNKI) databases. Pooled odds ratios (ORs) with their corresponding 95% confidence intervals (95% CIs) were used to evaluate the strength of the association under a fixed or random effect model according to heterogeneity test results. All analyses were performed using the Stata software, version 12.0. Twelve case-control studies were included in this meta-analysis with a total of 932 CML patients and 3,465 healthy controls. For MTHFR C677T (dbSNP: rs1801133, C>T), though the pooled ORs were not significant in the overall population, all the ORs greater than 1 suggested an increased risk of CML for carriers of the risk allele. However, stratified analysis based on genotyping method revealed a significant association in the PCR-restriction fragment length polymorphism (RFLP) subgroup, possibly as a result of heterogeneity. For MTHFR A1298C (dbSNP: rs1801131, A>C), the combined results showed that carriers of the C allele may be associated with a decreased risk of adult CML. Stratified analysis showed that the magnitude of this effect was especially significant among Asians, indicating ethnicity differences in adult CML susceptibility. This meta-analysis shows that the C allele of MTHFR A1298C may be associated with a decreased risk in adult CML, especially among Asians, while MTHFR C677T may not be associated with adult CML risk. However, the development of adult CML may be the result of gene-gene and gene-environment interactions, which should be considered in future individual GAS and subsequent meta-analyses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24379141     DOI: 10.1007/s13277-013-1554-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  51 in total

1.  C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.

Authors:  N Q Hanson; O Aras ; F Yang; M Y Tsai
Journal:  Clin Chem       Date:  2001-04       Impact factor: 8.327

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 3.  Leukaemia stem cells and the evolution of cancer-stem-cell research.

Authors:  Brian J P Huntly; D Gary Gilliland
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

4.  MTHFR C677T polymorphisms and childhood acute lymphoblastic leukemia: a meta-analysis.

Authors:  Jing Wang; Ping Zhan; Bing Chen; Rongfu Zhou; Yonggong Yang; Jian Ouyang
Journal:  Leuk Res       Date:  2010-04-20       Impact factor: 3.156

Review 5.  The World Health Organization (WHO) classification of the myeloid neoplasms.

Authors:  James W Vardiman; Nancy Lee Harris; Richard D Brunning
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

6.  C677T polymorphism of methylenetetrahydrofolate reductase may contribute to cervical cancer risk in complete over-dominant model.

Authors:  Hongmei Chen; Jin Zhu
Journal:  Med Hypotheses       Date:  2013-03-13       Impact factor: 1.538

7.  Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review.

Authors:  Stefania Boccia; Rayjean Hung; Gualtiero Ricciardi; Francesco Gianfagna; Matthias P A Ebert; Jing-Yuan Fang; Chang-Ming Gao; Tobias Götze; Francesco Graziano; Marina Lacasaña-Navarro; Dongxin Lin; Lizbeth López-Carrillo; You-Lin Qiao; Hongbing Shen; Rachael Stolzenberg-Solomon; Toshiro Takezaki; Yu-Rong Weng; Fang Fang Zhang; Cornelia M van Duijn; Paolo Boffetta; Emanuela Taioli
Journal:  Am J Epidemiol       Date:  2007-12-27       Impact factor: 4.897

8.  Genotyping of the MTHFR gene polymorphism, C677T in patients with leukemia by melting curve analysis.

Authors:  Ugur Deligezer; Ebru Akisik; Nejat Dalay
Journal:  Mol Diagn       Date:  2003

9.  Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies.

Authors:  Hee Nam Kim; Yeo-Kyeoung Kim; Il-Kwon Lee; Deok-Hwan Yang; Je-Jung Lee; Min-Ho Shin; Kyeong-Soo Park; Jin-Su Choi; Moo Rim Park; Deog Yeon Jo; Jong Ho Won; Jae-Yong Kwak; Hyeoung-Joon Kim
Journal:  Leuk Res       Date:  2008-09-06       Impact factor: 3.156

10.  Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia.

Authors:  Maja Krajinovic; Stephanie Lamothe; Damian Labuda; Emilie Lemieux-Blanchard; Yves Theoret; Albert Moghrabi; Daniel Sinnett
Journal:  Blood       Date:  2003-09-04       Impact factor: 22.113

View more
  4 in total

1.  Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase, dietary folate intake, and the risk of leukemia in adults.

Authors:  Ping Liu; Min Zhang; Xing Xie; Jie Jin; C D'Arcy J Holman
Journal:  Tumour Biol       Date:  2015-10-05

2.  Update meta-analysis from biomedical literature about MTHFR'polymorphisms and the CML' risk.

Authors:  Fatma Turki; Nour Louati; Hassen Kamoun; Leila Keskes; Tarek Rebaii; Rim Frikha
Journal:  Tunis Med       Date:  2022 avril

3.  B-Cell Chronic Lymphocytic Leukemia with 11q22.3 Rearrangement in Patient with Chronic Myeloid Leukemia Treated with Imatinib.

Authors:  Krzysztof Lewandowski; Michał Gniot; Maria Lewandowska; Anna Wache; Błażej Ratajczak; Anna Czyż; Małgorzata Jarmuż-Szymczak; Mieczysław Komarnicki
Journal:  Case Rep Med       Date:  2016-03-03

4.  Polymorphisms in the CYP2A6 and ABCC4 genes are associated with a protective effect on chronic myeloid leukemia in the Brazilian Amazon population.

Authors:  Natasha Monte; Karla B C C Pantoja; Juliana C G Rodrigues; Darlen C de Carvalho; Tereza C B Azevedo; Esdras E B Pereira; Paulo P de Assumpção; Sidney E B Dos Santos; Marianne R Fernandes; Ney P C Dos Santos
Journal:  Mol Genet Genomic Med       Date:  2021-05-29       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.